Research article · 5 Dec 2017
Research articlePublished 2015
Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: MicroRNAs (miRNAs) are known to play important roles in the diagnosis and prognosis of papillary thyroid cancer (PTC), and they are useful in developing targeted therapies. However, there have been no studies on the existence of racial differences in miRNAs expression that could explain differential overall survival of PTC patients. Expression analysis of miRNAs in major racial groups would be important for optimizing personalized treatment strategies. In the current study, we assessed the differential expression of 8 miRNAs between normal and tumor tissues, and also assessed racial differences between African American (AA) and Caucasian American (CA). Methods: First, the miRNA expression profiling was performed using formalin-fixed paraffin embedded (FFPE) tissue sections of tumor containing over 70% tumor cells. Normal and tumor sections of thyroid tissues were studied from AA and CA patients. The miRNA microarray profiling was done using miRBase version 18 (LC Sciences, Houston, TX, USA). Quantitative real-time PCR (qRT-PCR) was used to validate expression of 8 selected miRNAs. Results: Ingenuity pathway analysis showed involvement of target genes, such as Ras and NF-κB. Deregulated miRNAs such as miR-221 and miR-31 were found to be statistically significant between the two races. Using qRTPCR, we found that miR-21, miR-146b, miR-221, miR-222, miR-31, and miR-3613 were up-regulated while miR- 138 and miR-98 were down-regulated in tumors compared to normal tissues. Conclusion: Though sample size was small, we found several deregulated miRNAs having racial differences. The differential expression of miRNAs suggest that these miRNAs and their target genes could be useful to gain further mechanistic insight of PTC and their clinical implications, including miRNA replacement therapy or their knockdown strategies.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 29 Feb 2016
Expression of mitogen-activated protein kinases in papillary thyroid carcinoma
Conference abstract · 18 Dec 2017
Kaiso roles in racial disparity of TNBC prevalence and outcomes
Short communication · 21 Sep 2020
LIMD2: A novel therapeutic target for metastatic papillary thyroid carcinoma
Research article · 16 Jun 2016
Does Targeting BMI Help Reduce Racial Disparities and Improve Outcomes in Stage III Colorectal Cancer Patients?: A Retrospective Study
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Raagini Suresh”
- BylineArticles whose byline prints “Seema Sethi”
- BylineArticles whose byline prints “Shadan Ali”
- BylineArticles whose byline prints “Tamar Giorgadze”
- BylineArticles whose byline prints “Fazlul H. Sarkar”

